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Abstract
Background:  The staphylococcal QacA multidrug efflux protein confers resistance to an
exceptional number of structurally unrelated antimicrobial compounds. Aromatic amino acid
residues have been shown to be highly important for the transport function of several multidrug
transporters and are intimately involved in multidrug binding. This study investigated the structural
and functional importance of the seven tyrosine residues in QacA by examining the phenotypic
effect of incorporating conservative (aromatic) and non-conservative (non-aromatic) substitutions
for these residues.
Results: Determination of the resistance profiles and analysis of drug transport assays revealed
that non-conservative substitutions for most tyrosine residues influenced the QacA drug
recognition spectrum. However, an aromatic residue at three tyrosine positions, 63, 410 and 429,
was of importance for QacA-mediated transport and resistance to the majority of substrates
tested.
Conclusion: A tyrosine or phenylalanine residue at amino acid positions corresponding to 63 of
QacA in related drug efflux proteins is found to be highly conserved. Therefore, an aromatic side
chain at this position is likely to partake in a function common to these drug transporters, such as
proton translocation or essential intramolecular contacts, whereas aromatic residues at the non-
conserved 410 and 429 positions are expected to mediate a QacA-specific function, possibly
forming or stabilising part of the QacA drug binding region.
Background
The QacA multidrug efflux protein confers resistance to at
least 30 structurally distinct monovalent or bivalent cati-
onic lipophilic antimicrobials from at least 12 different
chemical families [1,2]. Furthermore, genes encoding
qacA or a highly related derivative are carried by wide-
spread clinical isolates of the human pathogen Staphyloco-
ccus aureus[3-5]. Therefore, the QacA multidrug resistance
protein facilitates an efflux mechanism by which strains of
S. aureus may currently overcome control measures, such
as the use of biocides within the clinical environment, and
spread to new hosts [1,3].
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The QacA polypeptide is composed of 514 amino acid res-
idues, organised into 14 α-helical transmembrane seg-
ments (TMS) (Figure 1) [6,7] and is classified as a member
of the drug:H+ antiporter (DHA) 2 family of the major
facilitator superfamily (MFS) of transport proteins [8].
Drug efflux mediated by QacA is powered by the proton-
motive-force and can be described using Michaelis-Men-
ton kinetics [9]. The drug binding region within QacA
appears to contain distinct binding sites for monovalent
and bivalent cationic antimicrobials [9]. Nonetheless,
biochemical studies of TMS lining the binding region
have suggested that these binding sites may be in proxim-
ity [10]. A clear requirement for an acidic residue in the
recognition of bivalent cationic substrates by QacA has
been established [6,10,11]. However, the location of this
residue within the binding region is flexible and appears
to influence the bivalent drug recognition spectrum of the
QacA protein [11].
Multidrug binding regions fundamentally differ from
binding sites required to bind only a single drug or group
of closely related drugs, in that they accommodate and
form stabilising interactions with large numbers structur-
ally diverse compounds. A number of studies have
attempted to delineate the mechanisms by which multid-
rug binding occurs [12]. These studies, including the
determination of several drug-bound crystal structures for
multidrug binding proteins [13-16], have demonstrated
that multidrug binding may be described as a process of
"induced-fit", i.e., each compound localises to a position
or positions within a multidrug binding region where it is
best accommodated and its binding is stabilised by a par-
ticular sub-set of amino acid side chains lining the region.
Common among the sub-sets of residues that mediate
interactions with drug compounds are aromatic residues
[13-16]. This is not surprising since the benzene group of
aromatic side chains potentiates a range of molecular
interactions which could stabilise binding of the typically
hydrophobic, planar and often cationic substrates of
multidrug binding proteins, including stacking, hydro-
phobic, π-π and cation-π interactions [17]. Beyond drug
binding within a secondary multidrug transport protein
Secondary structure model of the QacA multidrug transport protein Figure 1
Secondary structure model of the QacA multidrug transport protein. Topology of the QacA multidrug efflux protein 
based on hydropathy predictions and solvent accessibility analyses [6,7,10]. The membrane is depicted as a grey shaded band 
and the 14 TMS of QacA are shown in boxes numbered 1–14. The locations of the seven tyrosine residues and their amino 
acid substitutions within QacA are shown.BMC Microbiology 2008, 8:147 http://www.biomedcentral.com/1471-2180/8/147
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such as QacA, these types of molecular interactions could
also play a role in other functions, such as translocation of
coupling ions or the mediation of stabilising intramolecu-
lar contacts [18,19].
A previous study investigating the significance of tryp-
tophan residues within the QacA transport protein dem-
onstrated that those more highly conserved among QacA-
related transporters were the most functionally significant
[20]. In the current study the importance of the benzene
moiety within the tyrosine residues of the QacA transport
protein was determined. Of the seven tyrosine residues in
the QacA polypeptide, four are known or predicted to be
membrane embedded and three are thought to be located
within loop regions (Figure 1) [6,7,10]. The aromaticity of
the tyrosine residue at position 63 of QacA (Y63) is highly
conserved among DHA family transporters; a tyrosine, or
in some cases a phenylalanine, is almost exclusively found
at this position among these proteins [8]. Therefore, this
residue may function in a role common to these drug
efflux proteins, whereas the remaining six tyrosine resi-
dues could partake in functions unique to QacA. Conserv-
ative and non-conservative substitutions in terms of side-
chain aromaticity, phenylalanine and alanine, serine and/
or valine, respectively, were made for each of the tyrosine
residues in QacA and the mutants functionally analysed
(Figure 1).
Methods
Strains, plasmids, media and reagents
The E. coli strain DH5α [supE44 ΔlacU169 (ϕ80lacZΔM15)
hsdR17 recA1 endA1 gyrA96 thi-1relA1] [21] was used for
routine plasmid cloning procedures, Western blot analy-
ses and ethidium transport assays. E. coli BHB2600 (supE,
supF, hsdR, met) [22] was used in MIC analyses. The plas-
mids used were pBluescript II SK (Stratagene) and the
pBluescript-based qacA clone, pSK4322 [10]. Cultures of
E. coli cells were grown in Luria-Bertani media. Ampicillin
was used at a concentration of 100 μg ml-1 for plasmid
selection where appropriate.
Benzalkonium chloride, chlorhexidine dihydrochloride,
dequalinium chloride, ethidium bromide, pyronin Y and
carbonyl cyanide m-chlorophenylhydrazone were pur-
chased from Sigma and diamidinodiphenylamine dihy-
drochloride was obtained from Rhone-Poulenc Rorer
(Dagenham, UK). All other chemicals were of at least rea-
gent grade and purchased from commercial sources.
Substitution of wild-type tyrosine residues
The tyrosine residues within QacA were individually sub-
stituted using site-directed mutagenesis by the Stratagene
QuikChange method. Pairs of complementary oligonu-
cleotide primers (GeneWorks, Australia) were designed
with two positions of degeneracy to insert alanine, pheny-
lalanine, serine or valine substitutions for each of the
seven tyrosine codons in the qacA  gene carried on
pSK4322. The primer pairs also incorporated a silent
mutation which introduced an endonuclease restriction
site within the qacA sequence. The qacA gene sequences
within mutagenised pSK4322 derivatives, containing an
introduced restriction site, were sequenced (Australian
Genomic Research Facility, Brisbane) in their entirety to
identify the incorporated amino acid changes and to
ensure that undesired secondary mutations had not been
introduced elsewhere in the genes. Gene sequences were
stored and analysed using Sequencher version 4.2.2
(Gene Codes Corp.).
Western blot analyses
E. coli DH5α cells harbouring pSK4322-derived plasmids
expressing QacA mutants were cultured to OD600 = 0.6.
Equal volumes of cells were collected, lysed and electro-
phoresed on a 10% sodium dodecyl sulphate polyacryla-
mide gel electrophoresis gel. Proteins were transferred to
polyvinylidene difluoride membrane and probed using
an anti-QacA polyclonal antiserum [10] and a colourimet-
ric detection system. Membranes were scanned with a Bio-
Rad GS-710 calibrated imaging densitometer and
analysed by Quantity One® software (BioRad). Mutant
protein expression levels were expressed as a percentage of
the wild-type protein.
Minimum inhibitory concentration analyses
MIC analyses were conducted using solid Luria-Bertani
agar media supplemented with antimicrobial compounds
in the following concentration ranges: benzalkonium,
20–70 μg ml-1, chlorhexidine 1–20 μg ml-1, dequalinium
20–400 μg ml-1, diamidinodiphenylamine 50–500 μg ml-
1, ethidium 50–1800 μg ml-1, and pyronin Y 25–600 μg
ml-1. E. coli BHB2600 cells carrying pSK4322-derived plas-
mids encoding each QacA mutant protein were grown to
equivalent densities in the late exponential phase then
diluted 1:200 and replica plated onto plates containing
increasing concentrations of antimicrobials. Plates were
incubated at 37°C for up to 48 hours and the MIC deter-
mined as the lowest concentration of antimicrobial com-
pound required to fully inhibit bacterial growth.
Kinetic transport studies
Fluorimetric ethidium transport studies were conducted
essentially as described previously [9,23]. Briefly, E. coli
DH5α cells carrying pSK4322-derived plasmids encoding
each QacA mutant protein were grown to OD650 = 0.6,
then washed and resuspended in 20 mM HEPES buffer.
Cells were loaded with ethidium at concentrations rang-
ing from 0.1–25 μM in the presence of 10 μM carbonyl
cyanide  m-chlorophenylhydrazone. Ethidium loaded
cells were again washed and resuspended in 20 mM
HEPES, before transport was initiated by the addition ofBMC Microbiology 2008, 8:147 http://www.biomedcentral.com/1471-2180/8/147
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500 mM sodium formate. Transport was monitored fluor-
imetrically using a Hitachi 4500 fluorescence spectropho-
tometer with excitation and emission wavelengths of 530
and 610 nm, respectively.
Results
Construction of site-directed QacA tyrosine mutants
Site-directed mutagenesis using oligonucleotide primers
degenerate at two nucleotide positions within each tar-
geted codon was used to exchange tyrosine codons within
the qacA gene carried on pSK4322 for alanine, valine, ser-
ine, and/or phenylalanine. Phenylalanine substitutions
for each tyrosine residue were specifically isolated to
determine the effect of conservative (aromatic) tyrosine
substitutions on QacA function. Additionally, mutants
encoding at least one of alanine, serine or valine in place
of each tyrosine residue were isolated to examine the
importance of side-chain aromaticity at tyrosine positions
for the catalytic activity of the QacA transporter. In total,
genes encoding 16 tyrosine-substituted QacA mutants
were isolated for functional analyses (Figure 1). The
expression of these QacA variants was assessed using
semi-quantitative Western blot analysis. Each of the QacA
mutants was shown to be expressed at a level facilitating
functional studies, ranging from 32 to 132% of wild-type
QacA (Table 1).
Drug resistance profiles of the QacA tyrosine mutants
In order to gauge the functional consequences of QacA
tyrosine substitutions in the recognition and transport of
a range of chemically diverse QacA substrates, minimum
inhibitory concentration (MIC) analyses were conducted.
The resistance levels conferred by the QacA mutant pro-
teins to six compounds, representing five different chemi-
cal classes were tested: monovalent dyes (ethidium and
pyronin Y); monovalent quaternary ammonium com-
pounds (benzalkonium); bivalent quaternary ammo-
nium compounds (dequalinium); biguanidines
(chlorhexidine); and diamidines (diamidinodiphe-
nylamine).
Phenylalanine substitutions for the majority of the tyro-
sine residues in QacA did not have a significant bearing on
the capacity of QacA to mediate drug resistance (Table 1).
Indeed, only the Y410F derivative was notably affected
and then only in its capacity to mediate resistance to the
monovalent dyes ethidium and pyronin Y. Similarly, the
non-aromatic substituted Qac mutants, Y315A, Y366V
and Y501V, had no significant effect on drug resistance. In
Table 1: Phenotypic profiles of QacA tyrosine mutants
QacA mutation QacA expression (% wt QacA)c minimum inhibitory concentration (μg ml-1)a.b
monovalent substrates bivalent substrates
dyes Qacsd Bg Di
Et PyY Bc Dc Ch Dd
wt QacA 100 1200 500 50 350 12 300
vector N/A 400 50 30 100 2 100
Y63V 86 200 50 30 150 4 100
Y63F 50 1400 400 50 250 12 300
Y315A 64 800 500 50 300 12 400
Y315F 75 1000 500 50 300 12 300
Y358S 80 600 400 50 100 8 200
Y358F 34 1400 400 50 300 16 300
Y366A 106 1200 300 50 100 12 300
Y366V 50 1200 400 50 300 12 300
Y366F 99 800 500 50 300 12 400
Y410A 132 400 50 45 100 3 100
Y410V 67 200 50 30 100 7 300
Y410F 58 200 100 50 250 12 300
Y429S 57 200 200 30 250 4 100
Y429F 32 1400 500 60 300 14 400
Y501V 36 800 500 50 300 12 300
Y501F 47 1200 500 50 350 12 400
a MIC values were determined in E. coli BHB2600 cells expressing wild-type QacA or a mutant derivative and represent the lowest concentration of 
substrate required to fully inhibit bacterial growth.
b MIC experiments were conducted in at least triplicate and the median value is presented.
c QacA protein expression levels are the average of two repeat experiments.
d Abbreviations: Qacs, quaternary ammonium compounds; Bg, biguanidines; Di, diamidines; Et, ethidium; PyY, pyronin Y; Bc, benzalkonium; Dc, 
dequalinium; Ch, chlorhexidine; Dd, diamidinodiphenylamine.BMC Microbiology 2008, 8:147 http://www.biomedcentral.com/1471-2180/8/147
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contrast, Y63V, Y410A, Y410V, and Y429S non-aromatic
substitutions significantly reduced or abolished QacA-
mediated resistance to most representative QacA sub-
strates. Thus, these results suggest that aromatic residues
at positions 63, 410 and 429 participate in an aspect of
QacA-mediated transport common to all substrates. These
aromatic residues may function mechanistically, e.g., in
proton translocation or in facilitating intramolecular con-
formational transitions required for substrate transport.
Alternatively, these residues could compose part of the
QacA binding region universal to all substrates or stabilise
the binding region in the absence of substrate. Of the
remaining amino acid substitutions examined, three had
slight differential effects on substrate resistance where
Y358S and Y366A abolished QacA-mediated resistance to
the bivalent quaternary ammonium compound dequalin-
ium.
Kinetics of ethidium transport mediated by QacA tyrosine 
mutants
To complement the MIC analyses the kinetics of ethidium
transport were determined for each tyrosine-substituted
QacA mutant. In line with their inability to confer resist-
ance to ethidium, the Y63V, Y410A/V/F and Y429S QacA
mutants failed to mediate ethidium efflux (Figure 2). Fur-
thermore, mutants conferring only low-level ethidium
resistance, such as Y358S, displayed lower maximal rates
of transport than the wild-type protein and other func-
tional mutants (Figure 2). The remaining mutants dis-
played rates of ethidium transport approximately in line
with the wild-type QacA protein. The Km values derived for
the mutants functional in ethidium transport were
approximately equal to, or in some cases less than, that
determined for the wild-type QacA protein and do not
point towards reduced ethidium recognition as a result of
the incorporated mutations (Figure 2).
Discussion
The benzene moiety of aromatic amino acids affords these
residues versatility in molecular interactions, which is
ideal within the context of a multidrug transporter. For
example, drug binding, a key step in drug translocation by
multidrug transporters, requires the use of multidrug
binding regions that accommodate and stabilise the bind-
ing of a diverse array of chemical compounds. Such bind-
ing regions benefit from side-chains, such as those of
aromatic residues, capable of facilitating a range of molec-
ular contacts with the various structural moieties compos-
ing different drug substrates. Indeed, multidrug binding
regions, including those within the Escherichia coli multi-
drug transporters AcrB and EmrE and the S. aureus QacA
regulator protein QacR, which binds a similar range of
lipophilic cationic substrates to the QacA transporter, are
lined by numerous aromatic residues [13-16,24]. A
number of these residues have been determined to facili-
tate diverse structural interactions with different sub-
strates, making them key mediators of multidrug binding.
Furthermore, aromatic residues, Y92 and Y93 in particu-
lar, were seen to function as "drug surrogates" that stabi-
lise the multidrug binding region of the QacR regulator in
the absence of drug and are expelled upon drug binding
[16]. Interestingly, the expulsion of Y92 and Y93 in QacR
leads to a conformational change that dissociates the pro-
tein from DNA and allows qacA transcription [16]. It is
interesting to speculate that a similar scenario within a
multidrug transporter could provide the impetus for initi-
ating a translocation cycle. Beyond their roles within
multidrug binding regions, aromatic residues have been
shown to influence proton coupling within multidrug
transporters and may also play important structural roles
Kinetics of ethidium transport by QacA tyrosine mutants Figure 2
Kinetics of ethidium transport by QacA tyrosine 
mutants. Cells expressing each QacA derivative were 
loaded with various concentrations of ethidium and efflux 
monitored fluorimetrically after energisation. Vmax values 
(black bars) represent the maximal change in fluorescent 
units per second (ΔFU S-1) and Km values (white bars) are 
presented as μM ethidium. Transport assays were conducted 
in at least triplicate and the results of a representative exper-
iment are shown.
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in mediating TMS interactions or in guiding the depth of
TMS membrane insertion [18,25,26].
This study investigated the importance of a benzene moi-
ety at amino acid positions occupied by tyrosine residues
with the QacA multidrug transporter (Figure 1). Overall,
the tyrosine residues in the QacA protein were readily
replaceable with phenylalanine, indicating that the
hydroxyl group of the tyrosine side chains is not essential
in QacA-mediated transport function, although, a
hydroxyl moiety may be important at position 410 to
allow recognition of the monovalent dyes ethidium and
pyronin Y. In contrast, the benzene groups of the QacA
tyrosine residues were less dispensable. This was particu-
larly evident for the QacA Y63, Y410 and Y429 tyrosines,
which when replaced with non-aromatic residues resulted
in large reductions or the abolition of resistance to most
representative compounds and the complete loss of ethid-
ium transport capacity (Table 1; Figure 2). This suggests
that aromatic side chains at these positions are of general
importance for QacA-mediated transport function. Since
the aromaticity of Y63 in QacA is highly conserved among
DHA family transporters with varied drug recognition
profiles [8,23], it is likely that the benzene moiety of this
side chain functions in a mechanistic role common to
these proteins, possibly proton coupling as demonstrated
for Y4 of the E. coli EmrE transporter [18]. Although Y410
and Y429 of QacA are not conserved among related pro-
teins, these residues may also function mechanistically in
the QacA transport process, possibly in mediating con-
tacts between distal parts of the QacA polypeptide. Given
that the Y410F substitution affected only the transport of
monovalent dyes, Y410 may face into the QacA multidrug
binding region and mediate interactions with these sub-
strates via its hydroxyl group. In such a location, this resi-
due may also interact with other substrates via its benzene
moiety or could function similarly to Y92 and Y93 of
QacR and stabilise the QacA binding region in the
absence of drugs. Non-aromatic substitutions for Y358
and Y366 prevented resistance to dequalinium, implying
that these residues may function in dequalinium binding
or stabilise the dequalinium binding site.
Conclusion
Overall, the results of this study suggest a functional need
to maintain the aromaticity of a number of tyrosine resi-
dues within the QacA transport protein. In several cases,
modification of these residues for a non-aromatic residue
resulted in an altered drug recognition spectrum, hinting
at an involvement of these side chains in drug binding.
This finding is in keeping with previous studies of multi-
drug binding proteins which have identified aromatic res-
idues as key mediators of multidrug binding.
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